Inferior clinical outcome of the CD4+ cell count-guided antiretroviral treatment interruption strategy in the SMART study: Role of CD4+ cell counts and HIV RNA levels during follow-up

Lundgren, J D; Babiker, A; El-Sadr, W; Emery, S; Grund, B; Neaton, J D; Neuhaus, J; Phillips, A N; Gordin, F; Finley, E; Dietz, D; Chesson, C; Vjecha, M; Standridge, B; Schmetter, B; Grue, L; Willoughby, M; Demers, A; Phillips, A; Dragsted, U B; Jensen, K B; Fau, A; Borup, L; Pearson, M; Jansson, P O; Jensen, B G; Benfield, T L; Darbyshire, J H; Babiker, A G; Palfreeman, A J; Fleck, S L; Collaco-Moraes, Y; Cordwell, B; Dodds, W; van Hoff, F; Wazydrag, L; Cooper, D A; Drummond, F M; Connor, S A; Satchell, C S; Gunn, S; Oka, S; Delfino, M A; Merlin, K; McGinley, C; Duchene, A; Harrison, M; George, M; Hogan, C; Krum, E; Larson, G; Miller, C; Nelson, R; Roediger, M P; Schultz, T; Thackeray, L; Prineas, R; Campbell, C; Perez, G; Lifson, A; Duprez, D; Hoy, J; Lahart, C; Perlman, D; Price, R; Rhame, F; Sampson, J; Worley, J; Rein, M; Dersimonian, R; Brody, B A; Daar, E S; Dubler, N N; Fleming, T R; Freeman, D J; Kahn, J P; Kim, K M; Medoff, G; Modlin, J F; Moellering, R; Murray, B E; Pick, B; Robb, M L; Scharfstein, D O; Sugarman, J; Tsiatis, A; Tuazon, C; Zoloth, L; Klingman, K; Lehrman, S; Lazovski, J; Belloso, W H; Losso, M H; Benetucci, J A; Aquilia, S; Bittar, V; Bogdanowicz, E P; Cahn, P E; Casiró, A D; Cassetti, I

File(s) under permanent embargo

Inferior clinical outcome of the CD4⁺ cell count-guided antiretroviral treatment interruption strategy in the SMART study: Role of CD4⁺ cell counts and HIV RNA levels during follow-up

journal contribution

posted on 2008-04-15, 00:00 authored by J D Lundgren, A Babiker, W El-Sadr, S Emery, B Grund, J D Neaton, J Neuhaus, A N Phillips, F Gordin, E Finley, D Dietz, C Chesson, M Vjecha, B Standridge, B Schmetter, L Grue, M Willoughby, A Demers, A Phillips, U B Dragsted, K B Jensen, A Fau, L Borup, M Pearson, P O Jansson, B G Jensen, T L Benfield, J H Darbyshire, A G Babiker, A J Palfreeman, S L Fleck, Y Collaco-Moraes, B Cordwell, W Dodds, F van Hoff, L Wazydrag, D A Cooper, F M Drummond, S A Connor, C S Satchell, S Gunn, S Oka, M A Delfino, K Merlin, C McGinley, A Duchene, M Harrison, M George, C Hogan, E Krum, G Larson, C Miller, R Nelson, M P Roediger, T Schultz, L Thackeray, R Prineas, C Campbell, G Perez, A Lifson, D Duprez, J Hoy, C Lahart, D Perlman, R Price, F Rhame, J Sampson, J Worley, M Rein, R Dersimonian, B A Brody, E S Daar, N N Dubler, T R Fleming, D J Freeman, J P Kahn, K M Kim, G Medoff, J F Modlin, R Moellering, B E Murray, B Pick, M L Robb, D O Scharfstein, J Sugarman, A Tsiatis, C Tuazon, L Zoloth, K Klingman, S Lehrman, J Lazovski, W H Belloso, M H Losso, J A Benetucci, S Aquilia, V Bittar, E P Bogdanowicz, P E Cahn, A D Casiró, I Cassetti

Inferior clinical outcome of the CD4⁺ cell count-guided antiretroviral treatment interruption strategy in the SMART study: Role of CD4⁺ cell counts and HIV RNA levels during follow-up

History

Journal

Journal of Infectious Diseases

Volume

197

Issue

8

Pagination

1145 - 1155

Publisher

Oxford University Press (OUP)

Location

United States

Publisher DOI

https://doi.org/10.1086/529523

ISSN

0022-1899

eISSN

1537-6613

Language

en

Author URL

https://www.ncbi.nlm.nih.gov/pubmed/18476293

Publication classification

C1.1 Refereed article in a scholarly journal

Usage metrics

Keywords

Strategies for Management of Antiretroviral Therapy (SMART) Study Group

Licence

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

File(s) under permanent embargo

Inferior clinical outcome of the CD4+ cell count-guided antiretroviral treatment interruption strategy in the SMART study: Role of CD4+ cell counts and HIV RNA levels during follow-up

History

Journal

Volume

Issue

Pagination

Publisher

Location

Publisher DOI

ISSN

eISSN

Language

Author URL

Publication classification

Usage metrics

Categories

Keywords

Licence

Exports

Inferior clinical outcome of the CD4⁺ cell count-guided antiretroviral treatment interruption strategy in the SMART study: Role of CD4⁺ cell counts and HIV RNA levels during follow-up